I taped it.
I'll re-watch it and comment tomorrow.
If it was such a far fetched and improbable program, 60 minutes wouldn't have commented on it.
Let's not forget, it's not just about CTE.
"Exosome Sciences, Inc. (EXSCI), a majority owned subsidiary of Aethlon Medical, Inc., creates diagnostic tools to detect and quantify the presence of exosomes in blood and other fluids. Our lead product, the Enzyme Linked Lectin Specific Assay (ELLSA) has been validated to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, breast, lymphoma, and colorectal."
Working on another company first.
I'll let you know about it when I make my move. (if I do)
Meeting with attorneys next week.
SNGX will just have to wait.
SNGX: SGX942 Could be a Game Changer in the Treatment of Oral Mucositis
Actually, Dr. Sonis was quite positive on its prospects! there is nothing else available, at least with the efficacy that 942 shows.
He certainly convinced Zacks:
The interview with Dr. Sonis further convinces us that Soligenix SGX-942 has the potential to become the choice of agent for the management of OM resulted from HNC.
They did, this morning. In a way.
They state their objectives and results are on target and will be announced December 18.
In fact, their recent Press releases have shown great strides in their product being adopted by industry.
Please tell me why we are paying you half million dollars a year plus stock options.
You are not informing of ANYTHING going on.
In my eyes, and probably the court's eyes, you are guilty of malfeasance, not simply fiscal, but in operations and compliance areas.
Take care of the people who pay your salary. Time to take the tape off you mouth and start talking like normal CEO's do. If not, your stockholders will turn on you and the Board faster than a striped-assed jaybird.